medigraphic.com
ISSN 2992-7749 (Electronic)
ISSN 2992-7897 (Print)
Órgano Oficial de difusión científica de la Asociación Mexicana de Cirujanos de Columna A. C.

2026, Number 1

<< Back Next >>

Cir Columna 2026; 4 (1)

Efficacy of tranexamic acid in reducing perioperative blood loss and transfusion rates in multilevel spinal surgery: a retrospective cohort study

Robles OMJ, Robles ORE, Salinas CAN, Vargas CM

Language: Spanish
References: 29
Page: 12-18
PDF size: 270.96 Kb.


ABSTRACT

Introduction: complex spinal surgeries are often associated with significant blood loss, which can increase morbidity, the need for transfusions, and prolonged hospital stays. Tranexamic acid (ATX) is an antifibrinolytic agent used in various surgical specialties to reduce bleeding. Objective: to evaluate the efficacy of tranexamic acid in reducing intraoperative and postoperative bleeding and the need for transfusions in patients undergoing thoracolumbar or lumbosacral spine surgery with multilevel instrumentation. Material and methods: a retrospective cohort study was conducted in 67 patients who underwent surgery between March 2022 and March 2024. Two groups were compared: one received ATX (n = 23) and the other did not (n = 44). Clinical, transfusion, and hematological variables were analyzed. Results: no statistically significant differences were found in intraoperative blood loss volume or transfusion rates between the groups. However, the group treated with ATX showed slightly higher postoperative hemoglobin and hematocrit levels, with less variability. Conclusion: although the use of ATX did not show a significant reduction in blood loss or transfusions, it could promote greater postoperative hemodynamic stability. Prospective, multicenter studies with larger sample sizes are needed to confirm these findings.


REFERENCES

  1. Neilipovitz DT, Elgafy H, Bransford RJ, McGuire RA. Tranexamic acid for major spinal surgery. Eur Spine J. 2004; 13: S62-S65.

  2. Yi S, Yoon DH, Kim KN, Kim SH, Shin HC. Postoperative spinal epidural hematoma: risk factor and clinical outcome. Yonsei Med J. 2006; 47: 326-332.

  3. Willner D, Spennati V, Stohl S, Tosti G, Aloisio S, Bilotta F. Spine surgery and blood loss: systematic review of clinical evidence. Anesth Analg. 2016; 123: 1307-1315.

  4. Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander WA. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol. 2013; 27: 59-68.

  5. Zollo RA, Eaton MP, Karcz M, Pasternak R, Glance LG. Blood transfusion in the perioperative period. Best Pract Res Clin Anaesthesiol. 2012; 26: 475-484.

  6. Fletcher ND, Marks MC, Asghar JK, Hwang SW, Sponseller PD, Harms Study Group, et al. Development of consensus based best practice guidelines for perioperative management of blood loss in patients undergoing posterior spinal fusion for adolescent idiopathic scoliosis. Spine Deform. 2018; 6: 424-429.

  7. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013; 100: 1271-1279.

  8. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011; 3: CD001886.

  9. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012; 72: 585-617.

  10. Melander B, Gliniecki G, Granstrand B, Hanshoff G. Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. Acta Pharmacol Toxicol (Copenh). 1965; 22: 340-352.

  11. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine (Phila Pa 1976). 2000; 25: 596-601. doi: 10.1097/00007632-200003010-00010

  12. Farrokhi MR, Kazemi AP, Eftekharian HR, Akbari K. Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial. J Neurosurg Anesthesiol. 2011; 23: 290-296.

  13. Winter SF, Santaguida C, Wong J, Fehlings MG. Systemic and topical use of tranexamic acid in spinal surgery: a systematic review. Global Spine J. 2016; 6: 284-295.

  14. Hinev A, Paunov S. Mini-incision muscle-sparing lumbar approach to the kidney, the renal pelvis and the upper ureter. Urology. 2006; 68: 224.

  15. Cuellar JM, Yoo A, Tovar N, Coelho PG, Jimbo R, Vandeweghe S, et al. The effects of Amicar and TXA on lumbar spine fusion in an animal model. Spine (Phila Pa 1976). 2014; 39: E1132-E1137.

  16. Choi HY, Hyun SJ, Kim KJ, Jahng TA, Kim HJ. Effectiveness and safety of tranexamic acid in spinal deformity surgery. J Korean Neurosurg Soc. 2017; 60: 75-81.

  17. Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016; 39: 119-130.

  18. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006; 105: 1034-1046.

  19. Lin JD, Lenke LG, Shillingford JN, Laratta JL, Tan LA, Fischer CR, et al. Safety of a high-dose tranexamic acid protocol in complex adult spinal deformity: analysis of 100 consecutive cases. Spine Deform. 2018; 6: 189-194.

  20. Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014; 186: 318-327.

  21. Zhao Y, Xi C, Xu W, Yan J. Role of tranexamic acid in blood loss control and blood transfusion management of patients undergoing multilevel spine surgery. Medicine. 2021; 100: e24678. doi: 10.1097/md.0000000000024678

  22. Abdou M, Kwon J, Kim HJ, Lee B, Choi YS, Moon SH, et al. Tranexamic acid and intraoperative and postoperative accumulative bleeding in elective degenerative spine surgery. Yonsei Med J. 2022; 63: 927. doi: 10.3349/ymj.2022.0163

  23. Li X, Jiao G, Li J, Ji W, Hao Z, Gong F, et al. Combined use of tranexamic acid and rivaroxaban in posterior/transforaminal lumbar interbody fusion surgeries. Global Spine J. 2021; 13: 1229-1237. doi: 10.1177/21925682211024556

  24. Lotan R, Lengenova S, Rijini N, Hershkovich O. Intravenous tranexamic acid reduces blood loss in multilevel spine surgeries. J Am Acad Orthop Surg. 2022; 31: e226-e230. doi: 10.5435/jaaos-d-22-00738

  25. Honda A, Iizuka Y, Michihata N, Uda K, Mieda T, Takasawa E, et al. Effect of intraoperative tranexamic acid on perioperative major hemorrhage requiring transfusion. Global Spine J. 2022; 14: 804-811. doi: 10.1177/21925682221123317

  26. Wang Q, Liu J, Fan R, Chen Y, Yu H, Bi Y, et al. Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis. Eur Spine J. 2013; 22: 2035–2038. doi: 10.1007/s00586-013-2836-z

  27. Li ZJ, Fu X, Xing D, Zhang HF, Zang JC, Ma XL. Is tranexamic acid effective and safe in spinal surgery? Eur Spine J. 2013; 22: 1950-1957. doi: 10.1007/s00586-013-2774-9

  28. Dong W, Tang Y, Lei M, Ma Z, Zhang X, Shen J, et al. The effect of perioperative sequential application of multiple doses of tranexamic acid on postoperative blood loss after PLIF. Int J Surg. 2024; 110: 2122-2133. doi: 10.1097/JS9.0000000000001083

  29. Zhang D, Wu X, Kong Q, Wang Y, Zhang B, Feng P, et al. Prospective randomized controlled trial on the effectiveness of low-dose and high-dose intravenous tranexamic acid in reducing perioperative blood loss in single-level minimally invasive transforaminal lumbar interbody fusion. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022; 36: 439-445. doi: 10.7507/1002-1892.202112015




2020     |     www.medigraphic.com